Zhongguo aizheng zazhi

Editorial Office of China Oncology

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Zhongguo aizheng zazhi is an open-access journal published by Editorial Office of China Oncology in China, publishing in chinese and english. It is listed in DOAJ according to the sources read. Declared publication charge: 8,000 CNY. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Editorial Office of China Oncology
ISSN
1007-3639
Country
China
Languages
chinese, english
Access
Open access
Declared publication charge
8,000 CNY
Articles in DOAJ
2895
Declared review time
20 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2022-03-04
Indexing
DOAJ
APC
8,000 CNY
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Dormant — no works recorded since 2021
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

2895

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

2284

Last recorded publication year

2021

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

5

From OpenAlex open data (CC0).

Editorial & policy7
Last DOAJ review date
2025-03-21
Added to DOAJ
2022-03-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Acta Oncologica Sinica
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Lung Cancer Research Studies
  • Cancer-related Molecular Pathways
Show all subjects (75)
  • Esophageal Cancer Research and Treatment
  • Lung Cancer Treatments and Mutations
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Linguistic, Cultural, and Literary Studies
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Legal and Regulatory Analysis
  • Legal and Regulatory Analysis
  • Military Technology and Strategies
  • Colorectal Cancer Treatments and Studies
  • Breast Lesions and Carcinomas
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Endometrial and Cervical Cancer Treatments
  • Mechanisms of cancer metastasis
  • Ovarian cancer diagnosis and treatment
  • Advanced Radiotherapy Techniques
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Angiogenesis and VEGF in Cancer
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism
  • Cancer Cells and Metastasis
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related Molecular Pathways
  • Colorectal Cancer Surgical Treatments
  • Endometrial and Cervical Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cell death mechanisms and regulation
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Cancer-related gene regulation
  • Cancer-related gene regulation
  • Lymphoma Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Esophageal Cancer Research and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Cancer Treatment and Pharmacology
  • Cervical Cancer and HPV Research
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • HER2/EGFR in Cancer Research
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Metastasis and carcinoma case studies
  • Metastasis and carcinoma case studies
  • Estrogen and related hormone effects
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Estrogen and related hormone effects

Keywords (DOAJ)

  • oncology
  • clinical medicine
  • basic medical sciences

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: